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AbstrAct
Introduction Sleep length has been associated with 
obesity and various adverse health outcomes. The possible 
association of sleep length and respiratory symptoms has 
not been previously described. The aim of this study was 
to investigate the association between sleep length and 
respiratory symptoms and whether such an association 
existed independent of obesity.
Methods This is a multicentre, cross-sectional, 
population-based study performed in 23 centres in 10 
different countries. Participants (n=5079, 52.3% males) 
were adults in the third follow-up of the European 
Community Respiratory Health Survey III. The mean±SD 
age was 54.2±7.1 (age range 39–67 years). Information 
was collected on general and respiratory health and sleep 
characteristics.
results The mean reported nighttime sleep duration was 
6.9±1.0 hours. Short sleepers (<6 hours per night) were 
n=387 (7.6%) and long sleepers (≥9 hours per night) were 
n=271 (4.3%). Short sleepers were significantly more 
likely to report all respiratory symptoms (wheezing, waking 
up with chest tightness, shortness of breath, coughing, 
phlegm and bronchitis) except asthma after adjusting 
for age, gender, body mass index (BMI), centre, marital 
status, exercise and smoking. Excluding BMI from the 
model covariates did not affect the results. Short sleep was 
related to 11 out of 16 respiratory and nasal symptoms 
among subjects with BMI ≥30 and 9 out of 16 symptoms 
among subjects with BMI <30. Much fewer symptoms 
were related to long sleep, both for subjects with BMI 
<30 and ≥30.
conclusions Our results show that short sleep duration is 
associated with many common respiratory symptoms, and 
this relationship is independent of obesity.
IntroductIon
Over the past several decades, the prevalence 
of obesity has grown to epidemic propor-
tions.1 2 At the same time, there has been a 
similar epidemic of chronic sleep depriva-
tion.2–4 Studies have shown that the average 
sleep duration has decreased 1–2 hours over 
the last decades.2 According to annual surveys 
done by the National Sleep Foundation, 
by 1998, only 35% of American adults were 
obtaining 8 hours of sleep and that number 
had fallen to 20% on weekdays by 2008.2 It 
has also been reported that up to 30% of adult 
men and women between the ages of 30 and 
64 years sleep less than 6 hours per night.4
Sleep duration has been related to many 
important adverse effects on health.5–10 
Short sleep duration has been associated 
with diabetes, hypertension,10 cardiovascular 
disease (CVD)8 9 and increased mortality.5–7 
A recent meta-analysis of cross-sectional 
studies on sleep duration and the metabolic 
syndrome showed that sleep duration under 
5 hours significantly increased the risk for 
metabolic syndrome independently of other 
known risk factors.11
Obesity is strongly associated with respi-
ratory health, and sleep length is associated 
with obesity. The adverse health effects of 
sleep duration have been associated with 
body weight as both short sleepers and long 
Key messages
What is the key question?
Is sleep length associated with respiratory health and is 
this relationship independent of obesity?
What is the bottom line?
Short sleep duration is associated with many common 
respiratory symptoms, and this relationship is 
independent of obesity.
Why read on?
Respiratory symptoms have so far not been the main 
focus in studies on causal pathways of short sleep 
duration but, given our results, some respiratory 
symptoms might directly impact sleep quality and 
increase the risk of short sleep duration.
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sleepers are at an increased risk for obesity.12–14 In a 
recent meta-analyses of 16 studies including in total 
285 452 adults, both short sleep duration and long sleep 
duration were associated with an increased risk of weight 
gain, but only short sleep duration increased the risk of 
obesity.15 However, obesity has also been identified as a 
risk factor for both asthma16 and chronic bronchitis,17 
as well as obstructive sleep apnoea (OSA).18 In addition, 
several respiratory symptoms are related to obesity.19 20 
Despite the reported associations between sleep length 
and obesity, and obesity and respiratory health, to the 
best of our knowledge, no published studies have shown 
whether there is an independent association between 
sleep duration and respiratory symptoms. Since existing 
data show associations of both obesity and sleep dura-
tion and obesity and respiratory health, it is important to 
explore the associations of sleep duration and respiratory 
health and the role of obesity in this context.
The aim of this study was to investigate the possible 
association between sleep length and respiratory symp-
toms and whether it is independent of obesity.
Methods
subjects
This is a cross-sectional study, and participants are adults 
taking part in the third follow-up of the European 
Community Respiratory Health Survey (ECRHS, www. 
ecrhs. org) III, an international, multicentre, popula-
tion-based study of asthma and allergy, which was first 
performed in the early 1990s. Detailed descriptions of the 
methods for ECRHS I and ECRHS II have been published 
elsewhere.21 22 Briefly, participating centres were first 
randomly selected samples of subjects aged 20–44 years. 
Participants completed a short postal questionnaire about 
asthma and asthma-like symptoms (sample 1). Addition-
ally, about 20% random subsamples of responders were 
invited for a more detailed questionnaire administered 
by an interviewer (sample 2). Participants in this study 
belong to sample 2.
Ethical approval for the study from local research 
ethics committees and written consent from participants 
were obtained.
Questionnaires and measurements
Participants completed the core ECRHS questionnaires 
on smoking, other lifestyle and environmental factors, 
general and respiratory health and chronic disorders. 
‘Ever asthma’ was defined as reporting ever having had 
asthma where the diagnosis had been confirmed by a 
doctor, and ‘Current asthma’ was defined as having at 
least one asthma-related symptom in the last 12 months. 
Participants were also asked whether they had a problem 
with sneezing or a runny or blocked nose without having 
the influenza in the last 12 months.
Chronic obstructive pulmonary disease (COPD) was 
considered present if subjects reported physician-diag-
nosed COPD. Chronic bronchitis was defined as having 
cough or phlegm for at least 3 months every year for at 
least two consecutive years. The presence of CVD was 
determined by a positive response to ever having angina, 
heart attack, coronary heart disease or stroke. Nocturnal 
gastro-oesophageal reflex (nGOR) was defined as 
reporting heartburn or belching when in bed more often 
than once a week for the last 3 months.
Information on diagnosed depression, hypertension, 
diabetes and stroke was also collected.
Subjects were asked how often they usually exercised 
so much that they get out of breath or sweat. Answers 
ranged from never to every day, and those who answered 
≥2 times per week were considered to exercise on a 
regular basis.
Height and weight was measured by field workers 
according to a standardised procedure.
sleep-related questions
All participants were asked to fill in a short questionnaire 
on their sleep (see supplement). Participants answered 
the question: how much sleep do you estimate that you 
get on average each night? They were classified as short 
sleepers (<6 hours/night), normal sleepers (6–9 hours/
night) and long sleepers (≥9 hours/night), in accor-
dance with classifications used in most previous studies 
on health effects of sleep duration.7–9 12 13 Participants 
also answered the Epworth Sleepiness Scale.23
statistical methods
Data are presented as number and percentage or 
means±one SD, depending on distribution. For bivariate 
analysis, the χ2 test, t-test and one-way analysis of variance 
were used for nominal and continuous variables. Logistic 
regression was used for multivariable analyses to estimate 
the association between sleep length and respiratory 
symptoms. Given that obesity is strongly related to both 
sleep length and to respiratory disorders, multivariable 
models were built both with and without BMI adjust-
ment. We also stratified results according to BMI into two 
groups: subjects with BMI <30 and BMI ≥30. The logistic 
regression models for the association between short 
sleep and respiratory symptoms and disorders were also 
fitted separately for each country. Results for the associ-
ation were pooled across countries using random effects 
meta-analysis. Heterogeneity between the countries in 
the association between short sleep and respiratory heath 
were analysed. STATA V.13.0 was used for all statistical 
analyses.
results
the study cohort
We included a total of 5079 subjects (52.3% males) from 
23 centres in 10 countries (Australia, Britain, Denmark, 
Estonia, France, Germany, Iceland, Norway, Spain and 
Sweden).
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The mean age (±SD) of the cohort was 54.2±7.1 years 
(range: 39–67 years), mean BMI was 27.0±4.8 kg/
m2, 28.1% were obese (BMI ≥30), 33.2% were current 
smokers, 22.7% reported hypertension and 4.0% 
reported diabetes.
The mean sleep duration was 6.9±1.0 hours per night. 
Overall, the majority of subjects (88.1%) were normal 
sleepers (reporting sleeping 6–9 hours per night). 
Short sleepers (<6 hours per night) and long sleepers 
(≥9 hours per night) were 387 (7.6%) and 217 (4.3%) of 
the sample, respectively. Compared with short sleepers, 
normal sleepers were younger, had a lower BMI, were 
less likely to smoke, report hypertension or diabetes 
and were more likely to be married and to report exer-
cising regularly. Additionally, short sleepers had a higher 
prevalence of diabetes, hypertension and depression as 
compared with normal sleepers. Long sleepers were 
older, more likely to be females, had a higher BMI, were 
less likely to be married and had a higher prevalence 
of diabetes and depression as compared with normal 
sleepers (table 1).
The box plot in figure 1 shows the median number of 
hours slept per night and the range of reported sleep 
duration in the different centres in the study. Even though 
the median is the same between all centres (7 hours), 
there was a considerable variation in range and reported 
mean sleep duration between centres, ranging from 6.4 
in Huelva, Spain, to 7.1 hours per night in Reykjavik, 
Iceland (p<0.0001) (see figure 1).
There was also a considerable difference between 
centres in the prevalence of being a short sleeper (the 
lowest was 2% in Aarhus, Denmark, and the highest was 
20.7% in Huelva, Spain) (figure 2). The prevalence of 
long sleepers varied from 1.7% in Bergen, Norway, to 
9.8% in Oviedo, Spain.
sleep length And respIrAtory syMptoMs
All respiratory symptoms were more common in short 
sleepers as compared with normal sleepers (table 2). The 
prevalence of reporting having a blocked nose was also 
higher among short sleepers as compared with normal 
sleepers. Furthermore, short sleepers had a higher 
reported prevalence of nGOR and COPD as compared 
with normal sleepers. The only significant difference 
between long sleepers and normal sleepers was a higher 
prevalence of reporting shortness of breath after stren-
uous activity in long sleepers (table 2).
In the adjusted model, short sleep was associated to all 
respiratory and nasal symptoms except ever asthma and 
nasal allergies when the adjustment was without BMI. 
When BMI was also adjusted for, all symptoms except 
asthma were still associated with short sleep. Only a 
few symptoms were associated with long sleep duration 
(table 3).
The pooled estimates of the meta analyses of the 
association between short sleep and the respiratory vari-
ables were very similar to those found in table 3 (data 
not shown). No significant heterogeneity between the 
centres was found with the exception of the association 
between short sleep and shortness of breath following 
activity (pheterogneity=0.04), being woken by cough (pheterog-
neity=0.01) and cough during day and night in the winter 
(pheterogneity=0.03).
Table 1 Characteristics of short, normal and long sleepers
Short sleepers
(<6 hours per 
night) n=387
Normal sleepers
(6–9 hours per 
night) n=4475
Short compared 
with normal 
sleepers
p Value
Long sleepers
(≥9 hours per 
night) n=217
Long compared 
with normal 
sleepers
p Value
Male (%) 48.3 48.2 0.957 37.8 0.003
Age (years) 55.1±6.4 54.1±7.1 0.009 55.8±7.1 <0.001
BMI (kg/m2) 28.3±5.7 26.9±4.7 <0.001 27.4±5.4 0.04
ESS total 7.8±4.7 6.7±3.9 <0.001 6.4±4.7 0.25
BMI >30 (%) 37.2 27.1 <0.001 33.2 0.048
Married (%) 66.2 76.0 <0.001 65.7 0.013
Current smokers (%) 42.3 32.3 0.002 34.8 0.536
Exercise ≥2 × per week (%) 37.6 46.1 0.001 39.4 0.06
Reported lifetime morbidity
CVD (%) 5.0 3.9 0.31 6.1 0.12
Diabetes (%) 8.4 3.5 <0.001 6.1 0.05
Hypertension (%) 32.6 21.8 <0.001 23.8 0.48
Depression (%) 21.7 15.3 0.001 32.9 <0.001
Significance is marked as bold.
BMI, body mass index; CVD, cardiovascular disease; ESS, Epworth Sleepiness Scale.
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Table 4 shows the adjusted associations of respiratory 
and nasal symptoms and sleep length for subjects with 
BMI <30 and BMI ≥30. Short sleep was related to 11 out 
of 16 nasal and respiratory symptoms among subjects 
with BMI ≥30 and 9 out of 16 symptoms among subjects 
with BMI <30. Much fewer symptoms were related to 
long sleep, both for subjects with BMI <30 and ≥30 
(table 4).
Figure 1 The median number of hours slept per night and the range in sleep length in different centres. Centres are sorted 
by latitude (from North to South).
Figure 2 The prevalence (%) of being a short sleeper in different centres. Centres are sorted by latitude (from North to 
South).
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dIscussIon
Our results show that short sleep duration is associated 
with many common respiratory symptoms and that this 
relationship is independent of obesity.
Given the known relationship between sleep duration 
and obesity,15 and obesity and respiratory symptoms,19 20 
our hypothesis was that obesity was an important medi-
ator to a possible association between sleep duration and 
respiratory symptoms. Interestingly, we found a signif-
icant relationship between short sleep duration and 
respiratory symptoms independent of obesity.
Previous studies have shown a strong relationship 
between sleep duration and obesity,15 hypertension10 
and CVD.9 A recent study by Patel et al24 found that short 
sleep was significantly associated with obesity with an OR 
of 1.29 (95% CI 1.12 to 1.49) and a recent meta-anal-
ysis11 showed a U-shaped dose–response relationship 
between extremes of sleep duration and metabolic 
syndrome. Metabolic syndrome has also been shown to 
be an independent risk factor for worsening of respira-
tory symptoms, lung function impairment and asthma.25 
In our analysis, we made adjustments with and without 
BMI in order to better understand the role of BMI in the 
associations of sleep length and respiratory symptoms. 
We also divided our sample into two groups, a group with 
BMI <30 and BMI ≥30. We found in both groups a signif-
icant relationship between short sleep and respiratory 
symptoms. The high prevalence of respiratory symp-
toms associated with short sleep is therefore unlikely to 
be driven by the known associations of short sleep and 
obesity.
Our hypothesis was that obesity was a mediator in the 
relationship between sleep duration and respiratory 
symptoms. However, our results indicate a direct relation-
ship not mediated by BMI. It is possible that respiratory 
symptoms are directly disrupting sleep (people waking up 
because of coughing, blocked nose, and so on). Others 
have reported associations between sleep disturbances 
and respiratory disorders. Klink and Quan26 found that 
individuals with asthma and bronchitis reported a high 
prevalence of difficulties initiating and maintaining 
sleep as well as daytime sleepiness. Leng et al27 recently 
reported an association of excessive daytime napping 
with increased respiratory symptoms. In another general 
Table 2 The prevalence (%) of respiratory symptoms among short, normal and long sleepers
Short 
sleepers
(<6 hours per 
night) n=462
Normal 
sleepers
(6–9 hours per 
night) n=5136
Short compared 
with normal 
sleepers
p Value
Long 
sleepers
(≥9 hours per 
night) n=252
Long compared 
with normal 
sleepers
p Value
Wheezing last 12 months 35.7 23.2 <0.001 25.4 0.951
Woken with chest tightness last 
12 months
26.0 13.3 <0.001 17.7 0.105
Shortness of breath while at rest last 
12 months
14.0 6.8 <0.001 7.9 0.291
Shortness of breath after strenuous 
activity last 12 months
33.1 21.7 <0.001 30.2 0.006
Woken with shortness of breath last 
12 months
15.3 7.7 <0.001 8.1 0.152
Woken by coughing last 12 months 41.1 31.1 0.001 33.5 0.857
Cough in morning during the winter 18.7 10.8 <0.001 17.1 0.102
Cough during day or night during the 
winter
27.4 15.1 <0.001 19.1 0.928
Phlegm in morning during the winter 20.7 12.7 <0.001 16.0 0.635
Phlegm during day or night during the 
winter
19.3 10.1 <0.001 14.1 0.512
Chronic bronchitis 10.8 6.2 0.011 9.6 0.420
nGOR 20.0 14.0 <0.001 14.5 0.984
Asthma ever 17.5 18.9 0.474 23.1 0.224
COPD 2.2 1.2 0.017 2.0 0.590
Nasal allergies including hay fever 33.4 33.9 0.899 34.7 0.551
Nose blocked for >12 weeks last 
12 months
14.3 7.1 <0.001 10.0 0.244
Significance (p<0.05) is marked as bold. p Values show comparisons of short sleepers versus normal sleepers and long sleepers versus 
normal sleepers.
COPD, chronic obstructive pulmonary disease; nGOR, nocturnal gastro-oesophageal reflux.
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population study, specific respiratory symptoms such as 
coughing and wheezing were more predictive of sleep 
complaints than lung function or diagnosis of a lung 
disease.28 Furthermore, patients with COPD often expe-
rience sleep problems that lead to impaired quality of 
life.29 We have previously reported an association between 
asthma and reduced sleep quality and increased daytime 
sleepiness,30 31 and an association between asthma and 
short sleep duration was recently reported in a large 
sample of Korean females, aged 19–29 years.32 Others 
have reported similar associations in children.33 Further-
more, several studies have reported associations between 
respiratory symptoms and insomnia.34 35 It is however 
important to note that short sleepers in our study were 
more likely to smoke  and even though we adjusted for 
this in our analysis this could account for some of the 
increase in respiratory symptoms in this group.
A relationship between untreated OSA and difficul-
ties maintaining sleep has also been shown,36 where 
nighttime awakenings improve if OSA is treated,37 which 
supports the theory of respiratory disorders disrupting 
sleep. Short sleep could therefore be a marker of OSA, 
which is known to be associated to nGOR and other 
respiratory symptoms.38 Other studies have shown an 
association between OSA and short sleep duration.39 
The subjects in our study from the Icelandic centre did 
however all have an overnight sleep study where OSA was 
estimated40 and those who were diagnosed with OSA did 
not report shorter sleep than the other subjects.
Respiratory symptoms have so far not been the main 
focus in studies on causal pathways of short sleep dura-
tion, but given our results some respiratory symptoms 
might directly impact sleep quality and increase the risk 
of short sleep duration. Our results indicate that sleep 
length needs to be one of the variables studied when 
exploring respiratory symptoms, and it may also be 
important for clinician working with respiratory patients 
to ask about their sleep habits.
In the present study, we also found that being a long 
sleeper was associated with a few respiratory symp-
toms and disorders. Others have reported associations 
between having asthma and being a long sleeper,41 
which we replicated in this study among subjects with 
BMI ≥30 only. Many previous studies have also shown a 
strong association between long sleep, depression and 
increased mortality.41 42 The reason for the association 
between these respiratory symptoms and long sleep is not 
clear. It is possible that those with a history of respiratory 
Table 3 Adjusted associations of respiratory symptoms and being short sleeper and long sleeper. Adjustment with†  and 
without* BMI
Short sleepers
Adj. OR (95% CI) 
without BMI*
Short sleepers
Adj. OR (95% CI) 
with BMI †
Long sleepers
Adj. OR (95% CI) 
without BMI*
Long sleepers
Adj. OR (95% CI) 
with BMI 
Wheezing last 12 months 1.76 (1.29–2.39) 1.54 (1.12–2.13) 0.94 (0.60–1.45) 0.94 (0.59–1.50)
Woken with chest tightness last 12 months 2.37 (1.67–3.36) 2.10 (1.45–3.03) 1.24 (0.75–2.04) 0.98 (0.55–1.76)
Shortness of breath while at rest last 
12 months
2.47 (1.54–3.95) 2.42 (1.49–3.93) 1.30 (0.64–2.66) 0.97 (0.41–2.29)
Shortness of breath after strenuous activity 
last 12 months
1.81 (1.32–2.49) 1.55 (1.10–2.19) 1.75 (1.19–2.58) 1.80 (1.17–2.77)
Woken with shortness of breath last 
12 months
2.48 (1.62–3.81) 2.40 (1.55–3.72) 1.94 (1.07–3.51) 1.66 (0.85–3.22)
Woken by coughing last 12 months 1.54 (1.15–2.07) 1.43 (1.05–1.94) 1.12 (0.76–1.63) 1.10 (0.73–1.66)
Cough in morning during the winter 1.96 (1.37–2.83) 2.01 (1.38–2.92) 1.51 (0.92–2.47) 1.68 (1.00–2.80)
Cough during day or night during the winter 1.91 (1.37–2.66) 1.91 (1.35–2.70) 0.97 (0.58–1.60) 1.06 (0.63–1.79)
Phlegm in morning during the winter 1.83 (1.28–2.61) 1.81 (1.26–2.62) 1.24 (0.75–2.05) 1.28 (0.75–2.18)
Phlegm during day or night during the winter 2.00 (1.38–2.90) 2.02 (1.38–2.96) 1.17 (0.67–2.05) 1.04 (0.56–1.93)
Chronic bronchitis 1.74 (1.10–2.77) 1.63 (1.00–2.66) 1.39 (0.74–2.60) 1.29 (0.65–2.55)
Asthma ever 1.11 (0.73–1.69) 0.97 (0.62–1.52) 1.51 (0.95–2.42) 1.54 (0.93–2.54)
nGOR 1.82 (1.27–2.60) 1.74 (1.20–2.52) 0.87 (0.52–1.45) 0.92 (0.54–1.58)
Chronic bronchitis 1.74 (1.10–2.77) 1.63 (1.00–2.66) 1.39 (0.75–2.60) 1.23 (0.65–2.54)
COPD 2.73 (1.26–5.91) 2.64 (1.15–6.06) 1.30 (0.39–4.39) 1.98 (0.23–4.25)
Nasal allergies including hay fever 1.18 (0.86–1.62) 2.64 (1.15–6.06) 1.09 (0.74–1.61) 0.98 (0.23–4.25)
Nose blocked for >12 weeks last 12 months 2.66 (1.72–4.10) 2.66 (1.71–4.14) 2.07 (1.17–3.69) 1.74 (0.90–3.37)
Significance (p<0.05) is marked as bold. Logistic regression model. Normal sleep length was used as a reference group.
*Adjusted for gender, age, centre, marital status, exercise and current smoking.
†Adjusted for gender, age, centre, marital status, exercise and current smoking and BMI. 
BMI, body mass index; COPD, chronic obstructive pulmonary disease; nGOR, nocturnal gastro-oesophageal reflux.
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symptoms are more unwell and less active, which could 
facilitate longer sleep.41 Also, increased inflammation 
and elevated cytokines among subjects with respiratory 
symptoms could lead to increased fatigue and hence 
produce longer sleep.43–45 Our results show that short 
sleep is much more strongly related to respiratory symp-
toms than long sleep, but these associations need to be 
studied further.
There were considerable differences in sleep dura-
tion in different centres in our study and the highest 
percentage of short sleepers were in the Spanish centres. 
Cultural differences, such as siestas or afternoon napping, 
may impact sleep duration.
There are several limitation of this study that need to be 
considered. Our results are from a cross-sectional study, 
and deeper understanding of the underlying causal path-
ways can only come from prospective or intervention 
studies. Information regarding sleep duration was self-re-
ported without any objective measure on sleep time. 
However, sleep length, as reported in questionnaires, 
correlates well with sleep diaries.7 Also, most symptoms 
were reported as present for the past 12 months, and 
therefore it is not clear if these symptoms were currently 
present when the study took place. Furthermore, we did 
not have information on daytime napping, which could 
affect nighttime sleep length. The strengths of this study 
include the population-based nature of this large sample 
from many centres in 10 different countries and the use 
of standardised and validated procedures and instru-
ments.
To summarise, our results show that reporting respira-
tory symptoms is related to sleep duration, especially with 
reported short sleep. Short sleepers report more respi-
ratory symptoms, and this association is not confined to 
those who are obese. To our knowledge, this is the first 
report of an association between respiratory symptoms 
and sleep length in a large population-based cohort of 
middle-aged subjects. There is a need for prospective 
studies on sleep length and respiratory symptoms in 
order to clarify how short and/or long sleep are associ-
ated to respiratory health.
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Table 4 The adjusted* associations of respiratory disorders and sleep length for subjects with BMI <30 and subjects with 
BMI ≥30
Short sleepers
n=387
Long sleepers
n=217
BMI <30
n=243
BMI ≥30
n=144
BMI <30
n=145
BMI ≥30
n=72
Wheezing last 12 months 1.37 (0.92–2.04) 2.55 (1.53–4.26) 0.89 (0.51–1.56) 1.00 (0.48–2.12)
Woken with tight chest last 12 months 2.16 (1.39–3.37) 3.22 (1.75–5.94) 1.02 (0.53–1.98) 1.59 (0.70–3.62)
Shortness of breath while in rest last 
12 months
3.13 (1.74–5.63) 1.37 (0.59–3.19) 1.08 (0.38–3.07) 1.58 (0.55–4.50)
Shortness of breath after activity last 
12 months
1.47 (0.96–2.26) 2.33 (1.38–3.93) 1.94 (1.19–3.18) 1.48 (0.75–2.91)
Woken by shortness of breath last 12 months 2.51 (1.45–4.35) 2.48 (1.21–5.07) 2.86 (1.43–5.72) 0.87 (0.25–3.03)
Woken by coughing last 12 months 1.24 (0.85–1.81) 2.32 (1.40–3.85) 1.07 (0.67–1.72) 1.29 (0.66–2.54)
Cough in morning during the winter 1.71 (1.06–2.74) 2.45 (1.34–4.50) 1.30 (0.68–2.47) 2.38 (1.06–5.38)
Cough during day and night during the 
winter
1.72 (1.11–2.65) 2.32 (1.34–4.04) 1.01 (0.54–1.89) 0.84 (0.35–2.02)
Phlegm in morning during the winter 1.79 (1.14–2.83) 1.80 (1.00–3.25) 1.44 (0.79–2.65) 0.93 (0.36–2.39)
Phlegm during day and night during the 
winter
1.91 (1.19–3.06) 2.17 (1.15–4.09) 0.84 (0.39–1.83) 1.85 (0.78–4.39)
Asthma ever 1.02 (0.60–1.75) 1.27 (0.62–2.61) 1.09 (0.58–2.07) 2.78 (1.31–5.90)
nGOR 2.16 (1.36–3.41) 1.37 (0.75–2.49) 1.26 (0.70–2.27) 0.40 (0.13–1.18)
Chronic bronchitis 1.50 (0.77–2.88) 1.95 (0.97–3.95) 1.45 (0.67–3.12) 1.29 (0.42–3.94)
COPD 1.50 (0.78–2.88) 5.67 (1.62–19.8) 1.45 (0.67–3.13) 2.41 (0.46–12.7)
Nasal allergies including hay fever 1.16 (0.77–1.73) 1.26 (0.73–2.17) 1.19 (0.74–1.90) 0.94 (0.46–1.95)
Nose blocked for more than 12 weeks for the 
last 12 months
2.59 (1.49–4.49) 2.77 (1.31–5.84) 1.40 (0.62–3.15) 4.10 (1.67–10.08)
*Adjusted for gender, age, centre, marital status, exercise and current smoking. Significance (p<0.05) is marked as bold. Logistic regression 
model. Normal sleep length was used as a reference group.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; nGOR, nocturnal gastro-oesophageal reflux.
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